State Street
PROK icon

State Street’s ProKidney PROK Stock Holding History

State Street’s Portfolio PROK Stock Details PROK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.13M Buy
1,045,945
+489,100
+88% +$895K ﹤0.01% 3316
2026
Q1 		$997K Buy
556,845
+76,500
+16% +$162K ﹤0.01% 3488
2025
Q4 		$1.08M Buy
480,345
+5,388
+1% +$14.2K ﹤0.01% 3516
2025
Q3 		$1.15M Buy
474,957
+121,350
+34% +$323K ﹤0.01% 3479
2025
Q2 		$209K Sell
353,607
-1,372,716
-80% -$1.07M ﹤0.01% 3821
2025
Q1 		$1.51M Sell
1,726,323
-11,541
-0.7% -$16K ﹤0.01% 3334
2024
Q4 		$2.94M Buy
1,737,864
+309,546
+22% +$558K ﹤0.01% 3186
2024
Q3 		$2.74M Buy
1,428,318
+198,836
+16% +$451K ﹤0.01% 3210
2024
Q2 		$3.02M Buy
1,229,482
+286,883
+30% +$770K ﹤0.01% 3141
2024
Q1 		$1.55M Sell
942,599
-38,792
-4% -$57K ﹤0.01% 3359
2023
Q4 		$1.75M Buy
981,391
+73,544
+8% +$158K ﹤0.01% 3355
2023
Q3 		$4.16M Sell
907,847
-82,412
-8% -$789K ﹤0.01% 3012
2023
Q2 		$11.1M Buy
990,259
+929,878
+1,540% +$9.9M ﹤0.01% 2596
2023
Q1 		$684K Buy
60,381
+9,258
+18% +$98.5K ﹤0.01% 3645
2022
Q4 		$351K Buy
+51,123
New +$488K ﹤0.01% 3891

Other funds holding PROK

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
AGP
Artia Global Partners Miami, Florida $542M AUM 206.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

State Street's PROK Position: Q2 2026 in Review

State Street increased its ProKidney (PROK) stake by 88% in Q2 2026, buying an estimated $895K and bringing the position to 1,045,945 shares worth $2.13M. The position accounts for ﹤0.01% of the portfolio, ranked #3316.

State Street first reported a position in PROK in Q4 2022 and has held it in 15 quarters since. The position peaked at $11.1M in Q2 2023. 71 funds tracked by Wall St. Rank hold PROK as of Q2 2026.

  • State Street held 1,045,945 shares of ProKidney worth $2.13M as of Q2 2026.
  • State Street bought 489,100 ProKidney shares in Q2 2026, an estimated $895K.
  • ProKidney made up ﹤0.01% of State Street's portfolio in Q2 2026, its #3316 holding.
  • State Street first reported a position in ProKidney in Q4 2022 and has held it in 15 quarters since.
  • State Street's ProKidney position peaked at $11.1M in Q2 2023.
  • 71 funds tracked by Wall St. Rank held ProKidney as of Q2 2026.

Based on State Street's 13F filing for Q2 2026, filed 7 Aug 2026.